Format
Sort by

Send to

Choose Destination

Search results

Items: 17

1.
2.

Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.

Ugalde-Olano A, Egia A, Fernández-Ruiz S, Loizaga-Iriarte A, Zuñiga-García P, Garcia S, Royo F, Lacasa-Viscasillas I, Castro E, Cortazar AR, Zabala-Letona A, Martín-Martín N, Arruabarrena-Aristorena A, Torrano-Moya V, Valcárcel-Jiménez L, Sánchez-Mosquera P, Caro-Maldonado A, González-Tampan J, Cachi-Fuentes G, Bilbao E, Montero R, Fernández S, Arrieta E, Zorroza K, Castillo-Martín M, Serra V, Salazar E, Macías-Cámara N, Tabernero J, Baselga J, Cordón-Cardo C, Aransay AM, Villar AD, Iovanna JL, Falcón-Pérez JM, Unda M, Bilbao R, Carracedo A.

Methods. 2015 May;77-78:25-30. doi: 10.1016/j.ymeth.2015.02.005. Epub 2015 Feb 16. Review.

3.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.

Cozzi-Lepri A, Noguera-Julian M, Di Giallonardo F, Schuurman R, Däumer M, Aitken S, Ceccherini-Silberstein F, D'Arminio Monforte A, Geretti AM, Booth CL, Kaiser R, Michalik C, Jansen K, Masquelier B, Bellecave P, Kouyos RD, Castro E, Furrer H, Schultze A, Günthard HF, Brun-Vezinet F, Paredes R, Metzner KJ; CHAIN Minority HIV-1 Variants Working Group.

J Antimicrob Chemother. 2015 Mar;70(3):930-40. doi: 10.1093/jac/dku426. Epub 2014 Oct 21.

4.

HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment.

Castro E, Zhao H, Cavassini M, Mullins JI, Pantaleo G, Bart PA.

AIDS. 2014 Jul 31;28(12):1840-4. doi: 10.1097/QAD.0000000000000342.

PMID:
24911350
5.

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, Canderan G, Lawson B, Kopycinski J, Graham AS, Rowe DK, Smith MJ, Isern S, Michael S, Silvestri G, Vanderford TH, Castro E, Pantaleo G, Singer J, Gillmour J, Kiwanuka N, Nanvubya A, Schmidt C, Birungi J, Cox J, Haddad EK, Kaleebu P, Fast P, Sekaly RP, Trautmann L, Gaucher D.

J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9. Erratum in: J Clin Invest. 2014 Oct 1;124(10):4669. Gaucher, Denis [Added].

6.

NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.

Harari A, Rozot V, Cavassini M, Bellutti Enders F, Vigano S, Tapia G, Castro E, Burnet S, Lange J, Moog C, Garin D, Costagliola D, Autran B, Pantaleo G, Bart PA.

Eur J Immunol. 2012 Nov;42(11):3038-48. doi: 10.1002/eji.201242696. Epub 2012 Oct 1.

7.

Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection.

Castro E, Recordon-Pinson P, Cavassini M, Fleury H.

Antivir Ther. 2012;17(3):593-4. doi: 10.3851/IMP2024. Epub 2012 Jan 25. No abstract available.

PMID:
22301389
8.

HIV-1 drug resistance transmission networks in southwest Switzerland.

Castro E, Khonkarly M, Ciuffreda D, Bürgisser P, Cavassini M, Yerly S, Pantaleo G, Bart PA.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1233-8. doi: 10.1089/aid.2010.0083. Epub 2010 Sep 23.

PMID:
20860534
9.

Surveillance of HIV type 1 drug resistance among naive patients from Venezuela.

Castillo J, Comegna M, Quijada W, Jauvin V, Pinson P, Masquelier B, Fleury H, Castro E.

AIDS Res Hum Retroviruses. 2009 Dec;25(12):1329-33. doi: 10.1089/aid.2009.0118.

PMID:
19954301
10.

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.

Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, Filali-Mouhim A, Moser JM, Mehta RS, Drake DR 3rd, Castro E, Akondy R, Rinfret A, Yassine-Diab B, Said EA, Chouikh Y, Cameron MJ, Clum R, Kelvin D, Somogyi R, Greller LD, Balderas RS, Wilkinson P, Pantaleo G, Tartaglia J, Haddad EK, Sékaly RP.

J Exp Med. 2008 Dec 22;205(13):3119-31. doi: 10.1084/jem.20082292. Epub 2008 Dec 1.

11.

Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants.

Castro E, Bélair M, Rizzardi GP, Bart PA, Pantaleo G, Graziosi C.

AIDS Res Hum Retroviruses. 2008 Jan;24(1):106-13. doi: 10.1089/aid.2007.0139.

PMID:
18275355
12.

Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype.

Harari A, Cellerai C, Bellutti Enders F, Köstler J, Codarri L, Tapia G, Boyman O, Castro E, Gaudieri S, James I, John M, Wagner R, Mallal S, Pantaleo G.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16233-8. Epub 2007 Oct 2.

13.

HIV type 1 drug resistance among naive patients from Venezuela.

Bouchard M, Masquelier B, Moreno M, Deibis L, De Pérez GE, Fleury H, Castro E.

AIDS Res Hum Retroviruses. 2007 Mar;23(3):482-5.

PMID:
17411383
14.

Treatment options for anisohyperopia.

Granet DB, Christian W, Gomi CE, Banuelos L, Castro E.

J Pediatr Ophthalmol Strabismus. 2006 Jul-Aug;43(4):207-11; quiz 231-2.

PMID:
16915898
15.

High prevalence of secondary resistance mutations in Venezuelan HIV-1 isolates.

Dieudonne M, Garzaro D, Torres J, Naranjo L, Suárez JA, Castro J, Martínez N, Castro E, Berrueta L, Salmen S, Devesa M, Rangel HR, Pujol FH.

Invest Clin. 2006 Mar;47(1):27-34.

PMID:
16562642
16.

Trends of HIV-1 molecular epidemiology in Venezuela: introduction of subtype C and identification of a novel B/C mosaic genome.

Castro E, Moreno M, Deibis L, de Pérez G, Salmen S, Berrueta L.

J Clin Virol. 2005 Mar;32(3):257-8. No abstract available.

PMID:
15722034
17.

Molecular epidemiology of HIV-1 in Venezuela: high prevalence of HIV-1 subtype B and identification of a B/F recombinant infection.

Castro E, Echeverría G, Deibis L, González de Salmen B, Dos Santos Moreira A, Guimarães ML, Bastos FI, Morgado MG.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):338-44.

PMID:
12626896
Items per page

Supplemental Content

Loading ...
Write to the Help Desk